Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Latest research finds hypertension drug could be repurposed to delay ageing Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
News Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship
News Latest study uncovers findings of periodontal therapy in reducing rheumatoid arthritis disease activity
30 September 2022 Half of mild brain injury patients not recovering after six months, new commission warns Report published in Lancet Neurology highlights progress and unmet needs for traumatic brain injury prevention, care, and research
26 September 2022 Public support needed to tackle racial and other biases in AI for healthcare Members of the public are being asked to help remove biases based on race and other disadvantaged groups in artificial intelligence algorithms for healthcare
20 September 2022 Research identifies new treatment target for CNS injury and neurological disease Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.
16 September 2022 Professor of Metabolism and Inflammation awarded £828K British Heart Foundation Research Fellowship Professor Claudio Mauro has been awarded a British Heart Foundation Senior Research Fellowship towards research in immunometabolism in atherosclerosis.
07 September 2022 How the immune system tolerates friendly gut bacteria New understanding about how the gut balances between 'good' and 'bad' bacteria could provide new clues for managing chronic gut diseases
06 September 2022 Patient preferences surveyed to inform the development of acceptable new treatments Study part of new European recommendations for bringing patient preferences into drug development